In the Clinic|3 October 2017

Urinary Tract Infection

From VA Boston Healthcare System and Boston University School of Medicine, Boston, Massachusetts; Center for Innovations in Quality, Effectiveness, and Safety at the Michael E. DeBakey Veterans Affairs Medical Center and Baylor College of Medicine, Houston, Texas; and Houston VA Health Services Research and Development Center of Excellence, and Baylor College of Medicine, Houston, Texas.

Larissa Grigoryan, MD, PhD

From VA Boston Healthcare System and Boston University School of Medicine, Boston, Massachusetts; Center for Innovations in Quality, Effectiveness, and Safety at the Michael E. DeBakey Veterans Affairs Medical Center and Baylor College of Medicine, Houston, Texas; and Houston VA Health Services Research and Development Center of Excellence, and Baylor College of Medicine, Houston, Texas.

Barbara Trautner, MD, PhD

From VA Boston Healthcare System and Boston University School of Medicine, Boston, Massachusetts; Center for Innovations in Quality, Effectiveness, and Safety at the Michael E. DeBakey Veterans Affairs Medical Center and Baylor College of Medicine, Houston, Texas; and Houston VA Health Services Research and Development Center of Excellence, and Baylor College of Medicine, Houston, Texas.

From VA Boston Healthcare System and Boston University School of Medicine, Boston, Massachusetts; Center for Innovations in Quality, Effectiveness, and Safety at the Michael E. DeBakey Veterans Affairs Medical Center and Baylor College of Medicine, Houston, Texas; and Houston VA Health Services Research and Development Center of Excellence, and Baylor College of Medicine, Houston, Texas.

Disclosures: Dr. Gupta, ACP Contributing Author, reports personal fees from Paratek Pharmaceuticals, Iterum Therapeutics, Tetraphase Pharmaceuticals, Ocean Spray, UpToDate, and Melinta Therapeutics outside the submitted work and chairs the Infectious Diseases Society of America guidelines on urinary tract infection. Dr. Grigoryan, ACP Contributing Author, reports a grant from Zambon Pharmaceuticals outside the submitted work. Dr. Trautner, ACP Contributing Author, reports grants from the National Institutes of Health, the U.S. Department of Veterans Affairs Health Services Research and Development Service, and Zambon Pharmaceuticals and other support from Zambon Pharmaceuticals outside the submitted work. Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M17-1676.

Editors' Disclosures: Christine Laine, MD, MPH, Editor in Chief, reports that she has no financial relationships or interests to disclose. Darren B. Taichman, MD, PhD, Executive Deputy Editor, reports that he has no financial relationships or interests to disclose. Cynthia D. Mulrow, MD, MSc, Senior Deputy Editor, reports that she has no relationships or interests to disclose. Deborah Cotton, MD, MPH, Deputy Editor, reports that she has no financial relationships or interest to disclose. Jaya K. Rao, MD, MHS, Deputy Editor, reports that she has stock holdings/options in Eli Lilly and Pfizer. Sankey V. Williams, MD, Deputy Editor, reports that he has no financial relationships or interests to disclose. Catharine B. Stack, PhD, MS, Deputy Editor for Statistics, reports that she has stock holdings in Pfizer and Johnson & Johnson.

With the assistance of additional physician writers, the editors of Annals of Internal Medicine develop In the Clinic using MKSAP and other resources of the American College of Physicians.

Abstract

Urinary tract infections (UTIs) are common in both inpatient and outpatient settings. This article provides an evidence-based, clinically relevant overview of management of UTIs, including screening, diagnosis, treatment, and prevention. Conditions covered include acute cystitis (both uncomplicated and complicated), catheter-associated UTI, and asymptomatic bacteriuria in both women and men.